Medical Communications

Showing 15 posts of 6402 posts found.

shutterstock_235920349

GSK offers concessions ahead of planned venture with Pfizer

June 21, 2019 Medical Communications, Sales and Marketing GSK, Pfizer, pharma

The European Commission has said that GlaxoSmithKline has offered concessions to address concerns relating to the British multinational’s planned joint …

Alimera Sciences secures NICE recommendation for uveitis eye implant

June 21, 2019 Medical Communications, Sales and Marketing Alimera Sciences, NICE, UK, pharma, uveitis

Britain’s cost effectiveness body NICE has recommended the use of the fluocinolone acetonide implant, a new treatment option for patients …
28246711066_52e38bc591_z

No-deal Brexit could cause shortages and higher prices, healthcare distributors warn

June 19, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, brexit, distribution, pharma, supply chain

The Healthcare Distribution Association (HDA) has warned MPs that Britain could face shortages of medicines if it were to leave …
millerblockchainadj-1600x1200

The missing link: Blockchain in clinical data management

June 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, blockchain, data, data management, pharma, supply chain

Louis Goss explores the potential uses for the much-hyped technology blockchain as a tool to tackle the data management challenges …
gilead_hq_at_stockley_park_london_2

Gilead inks deal with Canadian antibody discovery firm AbCellera

June 14, 2019 Medical Communications AbCellera, Gilead, monoclonal antibodies, pharma

Gilead has entered into an agreement with Canadian monoclonal antibody discovery firm AbCellera. The two firms will take part in …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

June 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, GSK, J&J, JJ, Otsuka, Pfizer, Purdue, Sanofi, Vertex, pharma

Pfizer supressed research showing their arthritis drug Enbrel reduced the risk of Alzheimer’s. This was the big revelation this week! …
merckincweb2

FDA ask MSD to join blockchain supply chain network

June 14, 2019 Medical Communications FDA, MSD, Merck, blockchain, supply chain

The FDA has asked MSD to join a shared permission blockchain network to help track and trace prescription medicines and …
teva_copy

Teva recall heart drug after carcinogen found in API

June 14, 2019 Medical Communications API, Contamination, NMDA, Teva, carcinogen, pharma, recall

Teva Pharmaceuticals has expanded its recall of losartan potassium tablets after detecting a possible carcinogen in an active pharmaceutical ingredient …
800px-uc-berkeley-campus-overview-from-hills

GSK sets up new CRISPR lab with UC, Berkeley

June 13, 2019 Medical Communications GSK, UC, berkely, crispr, genetics, pharma

GSK has struck a $67 million deal with the University of California, Berkeley. British multinational GlaxoSmithKline will collaborate with UC, …
dr_aiden_cottrell

GSK tech exec joins Institute of Cancer Research

June 13, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Institute of Cancer Research (ICR) has said GlaxoSmithKline’s Dr Adrian Cottrell will join as the institute’s new Chief Information …

J&J and Colgate pay $4.8 million each to woman in California

June 13, 2019 Business Services, Medical Communications Cancer, J&J, JJ, lawsuit, pharma, talc

A California court has said Johnson & Johnson and Colgate-Palmolive must pay a total of nearly $10 million to a …
cq5dam

AstraZeneca spends more than twice as much as expected on new HQ

June 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, UK, headquarters, pascal soriot, pharma

AstraZeneca’s new headquarters in Cambridge, United Kingdom are expected to cost more than double the sum of £330 million that …
paul-hudson-big-image

Novartis Pharma head to become new Sanofi CEO

June 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Paul Hudson, appointment, olivier brandicourt

French drugmaker Sanofi has revealed that its CEO Olivier Brandicourt is to retire from the role, to be replaced with …
ward_lilley

Vectura CEO to step down at end of June

June 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, pharma, vectura

Vectura is on course for a new leader to take up the company’s reins after it was revealed that CEO …

Implementing “the safest medicines system in the world”

June 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, packaging, pharma

With debates heating up over cooperation between European across the continent, Matt Fellows investigates the current state of packaging countermeasures …
The Gateway to Local Adoption Series

Latest content